BRIEF published on 07/10/2024 at 07:35, 2 years ago Evotec and Pfizer Collaborate to Advance Drug Discovery in France Drug Discovery Metabolic Diseases Evotec Pfizer Infectious Diseases
PRESS RELEASE published on 07/10/2024 at 07:30, 2 years ago Evotec and Pfizer collaborate to advance drug discovery in France Evotec SE collaborates with Pfizer to focus on early discovery research for metabolic and infectious diseases in France. The multi-year agreement includes research support and potential milestones Drug Discovery Evotec SE France Pfizer Metabolic And Infectious Diseases
BRIEF published on 07/08/2024 at 14:05, 2 years ago Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz Partnership Biosimilars Evotec Sandoz Biologics
PRESS RELEASE published on 07/08/2024 at 14:00, 2 years ago Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz Evotec SE's biologics segment, Just - Evotec Biologics, expands partnership for biosimilars with Sandoz, securing long-term commercial supply. Collaboration aims for cost-efficient development Evotec SE Biosimilars Just - Evotec Biologics Sandoz Commercial Supply
BRIEF published on 06/25/2024 at 07:35, 2 years 1 month ago Just-Evotec Biologics Selected by U.S. DOD for Manufacturing Optimization Evotec SE Biologics Manufacturing U.S. Department Of Defense Monoclonal Antibodies Medical Countermeasures
PRESS RELEASE published on 06/25/2024 at 07:30, 2 years 1 month ago Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program Just \/ Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program. Evotec SE subsidiary chosen for $39m accelerated mAb development project Evotec SE Just - Evotec Biologics U.S. Department Of Defense Manufacturing Optimization Program MAb Development
BRIEF published on 06/12/2024 at 07:35, 2 years 1 month ago Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb Collaboration Neuroscience Evotec Neurodegenerative Diseases Bristol Myers Squibb
PRESS RELEASE published on 06/12/2024 at 07:30, 2 years 1 month ago Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb Evotec SE makes progress in neuroscience collaboration with Bristol Myers Squibb, receiving a US$20m research payment. The partnership focuses on developing treatments for neurodegenerative diseases Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Neuroscience Collaboration Research Payment
BRIEF published on 06/10/2024 at 18:05, 2 years 1 month ago Evotec SE: Results of the Annual General Meeting 2024 Shareholders Supervisory Board Evotec Approval AGM 2024
PRESS RELEASE published on 06/10/2024 at 18:00, 2 years 1 month ago Evotec SE: Results of the Annual General Meeting 2024 Evotec SE shareholders approve most proposals at the Annual General Meeting 2024. Dr Duncan McHale and Wesley Wheeler elected to the Supervisory Board, replacing Dr Elaine Sullivan and Dr Mario Polywka Annual General Meeting Shareholders Evotec SE Supervisory Board Business Performance
Published on 08/01/2026 at 01:20, 2 days 12 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 12 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 13 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 2 days 14 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/03/2026 at 13:32, 18 minutes ago Dr. jur. Michael Jaffé, Insolvency administrator of Electrochaea GmbH: Global patent portfolio for the production of green gas monetized - Hitachi takes over further development of the technology
Published on 08/03/2026 at 12:47, 1 hour 2 minutes ago EQS-Adhoc: Sirma Group JSC: Transactions in Own Shares under the Share Buyback Program
Published on 08/03/2026 at 12:33, 1 hour 17 minutes ago Diginex Announces Secured US$70 Million Funding Commitments and Extension of Long-Stop Date for Proposed Acquisition of Resulticks
Published on 08/03/2026 at 12:33, 1 hour 17 minutes ago EQS-Adhoc: Beiersdorf Aktiengesellschaft: Beiersdorf adjusts guidance for the full year 2026 and resolves NIVEA turnaround plan for the next 18 months
Published on 08/03/2026 at 12:23, 1 hour 27 minutes ago EQS-Adhoc: elumeo SE has entered into an agreement with a litigation funder and files a lawsuit for damages against Vodafone
Published on 08/03/2026 at 10:58, 2 hours 51 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from July 27 to July 31 2026
Published on 08/03/2026 at 08:29, 5 hours 21 minutes ago Launch of a €225 million tranche of its share buyback programme
Published on 08/03/2026 at 07:00, 6 hours 50 minutes ago BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 07/31/2026 at 21:00, 2 days 16 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 18 hours ago Share retention commitments (Dutreil Agreement)
